未登录

Z

Zhongqing Wang

hec pharm group

H指数:14

被引数:551

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a Scalable Synthesis for the Spirocyclic Benzoxepane–Pyridine Core of FXR Agonist HEC96719

开发一种可扩展合成方法用于FXR激动剂HEC96719螺环苯并氧杂环庚烷-吡啶核心

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2026-07-010

PRE

Access to [2.2]Paracyclophane-Fused N-Heterocycles via Palladium-Catalyzed C-H Activation and Cyclization of [2.2]Paracyclophaneacylhydrazones with Vinyl Azides

通过钯催化[2.2]对环芳基酰肼与乙烯基叠氮的C-H活化与环化反应制备[2.2]对环芳基稠合N-杂环。

ORGANIC LETTERS

IF5

2025-05-130

PRE

Efficient bio-reduction of 3-nitro phthalic acid using engineered nitroreductase and V2O5

PROCESS BIOCHEMISTRY

IF4

2025-01-010

PRE

Effects of acupuncture at limb Acupoints-Guangming (GB37) on UDVA, CS, and EEG microstate in myopia

FRONTIERS IN NEUROSCIENCE

IF3.2

2024-11-210

OAAI

Identification, Synthesis, Characterization, and Control Strategy Establishment for Process Impurities of Baloxavir Marboxil

巴洛沙韦的鉴定、合成、表征及工艺杂质控制策略的建立

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2024-03-221

PRE

Degradation Mechanism Study for Secondary Degradants in Rosuvastatin Calcium and Determination of Degradant Acetaldehyde Using Static Headspace Gas Chromatography Coupled with Matrix Precipitation

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2024-02-011

PRE

Development of Scalable Processes for the Preparation of 4-(chloromethyl)-1-cyclohexyl-2-(trifluoromethyl)benzene: A Key Intermediate for Siponimod

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2023-07-212

PRE

Development and validation of a stability-indicating RP-HPLC method for the determination of fifteen impurities in rivaroxaban

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2023-05-016

PRE

Process Development and Optimization of Linagliptin Aided by the Design of Experiments (DoE)

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2022-11-166

PRE

Development of a Robust and Scalable Process for the Large-Scale Preparation of Vilazodone

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2022-09-290

PRE

Efficient Synthesis of a Key Intermediate for Moxifloxacin Via Intramolecular Double Stereodifferentiation

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2022-07-281

PRE

Special Application of ms/ms Method on Determination of Regiochemistry of Sugammadex Series Compounds: Synthesis, Isolation and Structural Characterization for Two Potential Oxidative Impurities in Sugammadex Sodium Finished Pharmaceutical Product

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2022-02-011

PRE

Electrocatalytic oxygen reduction of COF-derived porous Fe-Nx nanoclusters/carbon catalyst and application for high performance Zn-air battery

COF衍生的多孔fe-nx纳米簇/碳催化剂的电催化氧还原及其在高性能锌-空气电池中的应用

MICROPOROUS AND MESOPOROUS MATERIALS

IF4.7

2022-01-0113

PRE

Organocatalytic Asymmetric Arylation of p-Quinone Phosphonates: A Green Access to Biaryl Monophosphorus Ligands

ORGANIC LETTERS

IF5

2021-09-229

PRE

Efficient Synthesis of a Key Intermediate for Baloxavir Marboxil from a Greener Starting Material: Ethylene Glycol

从更绿色的起始原料有效合成巴洛沙韦的关键中间体: 乙二醇

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2021-09-088

PRE

Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability (vol 22, 142, 2021)

AAPS PHARMSCITECH

IF4

2021-06-141

OA

η6-Arene CH-O Interaction Directed Dynamic Kinetic Resolution - Asymmetric Transfer Hydrogenation (DKR-ATH) of α-Keto/enol-Lactams

ADVANCED SYNTHESIS & CATALYSIS

IF4

2021-05-288

PREAI

Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability

AAPS PHARMSCITECH

IF4

2021-04-2313

PRE

Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat

ORGANIC PROCESS RESEARCH & DEVELOPMENT

IF3.5

2021-03-054

PREAI

Access to Cycloalkeno[c]-Fused Pyridines via Pd-Catalyzed C(sp2)-H Activation and Cyclization of N-Acetyl Hydrazones of Acylcycloalkenes with Vinyl Azides

ORGANIC LETTERS

IF5

2020-09-2920

PREAI